RESECTABLE PANCREATIC CARCINOMA
Clinical trials for RESECTABLE PANCREATIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug trial aims to keep pancreatic cancer from coming back
Disease control Recruiting nowThis study is testing if adding the drug olaparib after surgery and chemotherapy can help prevent pancreatic cancer from returning. It is for patients whose cancer has been surgically removed and who have specific genetic mutations (BRCA1, BRCA2, or PALB2). Participants will take…
Matched conditions: RESECTABLE PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Scientists watch Cancer's blood supply live during surgery
Knowledge-focused Recruiting nowThis study aims to learn more about the tiny blood vessels that feed solid tumors. Researchers will use a special microscope during a patient's standard cancer surgery to see these vessels in real time. The goal is to understand how tumor blood flow works and if it relates to how…
Matched conditions: RESECTABLE PANCREATIC CARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC